United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2023_register executive 2023-08-01 article Rules and Regulations D09002ee1d2cd415e D09002ee1d2cd41d2 United States Department of Justice originator org United States Government Agency or Subagency United States Drug Enforcement Administration originator org United States Government Agency or Subagency On December 18, 2014, the Designer Anabolic Steroid Control Act of 2014 (DASCA) became law. The Act amended the Controlled Substances Act to revise and add specified substances to the definition of "anabolic steroid." The Act provided a new mechanism for temporary and permanent scheduling of anabolic steroids, and added specific labeling requirements for products containing anabolic steroids. The Drug Enforcement Administration (DEA) is publishing this rule to amend and reorganize its regulations to make them consistent with DASCA regarding the updated definition, specific substances, criteria and timeframes applicable to temporary and permanent scheduling of anabolic steroids, and labeling requirements. 88 FR 50036 https://www.govinfo.gov/app/details/FR-2023-08-01/2023-15747 2023-15747 fr01au23-10 RIN 1117-AB81 4410-09-P Docket No. DEA-481 https://www.govinfo.gov/app/details/FR-2023-08-01/2023-15747 https://www.govinfo.gov/content/pkg/FR-2023-08-01/html/2023-15747.htm https://www.govinfo.gov/content/pkg/FR-2023-08-01/pdf/2023-15747.pdf Chemicals Drug Traffic Control Exports Imports Labeling Packaging and Containers Administrative Practice and Procedure Reporting and Recordkeeping Requirements 6 p. 50036 50041 88 FR 50036 Title 21 Part 1300 21 CFR Part 1300 Title 21 Part 1302 21 CFR Part 1302 Title 21 Part 1308 21 CFR Part 1308 RIN 1117-AB81 Implementation of the Designer Anabolic Steroid Control Act of 2014; Federal Register Vol. 88, Issue RULE 2023-15747 DEPARTMENT OF JUSTICE Drug Enforcement Administration 2023-08-01 Docket No. DEA-481 4410-09-P 2023-15747 Final rule.

On December 18, 2014, the Designer Anabolic Steroid Control Act of 2014 (DASCA) became law. The Act amended the Controlled Substances Act to revise and add specified substances to the definition of "anabolic steroid." The Act provided a new mechanism for temporary and permanent scheduling of anabolic steroids, and added specific labeling requirements for products containing anabolic steroids. The Drug Enforcement Administration (DEA) is publishing this rule to amend and reorganize its regulations to make them consistent with DASCA regarding the updated definition, specific substances, criteria and timeframes applicable to temporary and permanent scheduling of anabolic steroids, and labeling requirements.

This final rule is effective August 1, 2023. Terrence L. Boos, Ph.D., Chief (DOE), Diversion Control Division, Drug Enforcement Administration; Mailing Chemicals Drug Traffic Control Exports Imports Labeling Packaging and Containers Administrative Practice and Procedure Reporting and Recordkeeping Requirements Implementation of the Designer Anabolic Steroid Control Act, https://apps2.deadiversion.usdoj.gov/contactDea/spring/fullSearch Vol. 88, no. 146 Office of the Federal Register, National Archives and Records Administration 2023-08-01 continuing daily deposited born digital 547 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2023-08-01 P0b002ee1bfbc0d3b 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr01au23 https://www.govinfo.gov/app/details/FR-2023-08-01 https://www.govinfo.gov/content/pkg/FR-2023-08-01/pdf/FR-2023-08-01.pdf https://www.govinfo.gov/content/pkg/FR-2023-08-01/xml/FR-2023-08-01.xml fdlp 49993 50532 DGPO 2023-08-01 2025-05-14 FR-2023-08-01 machine generated eng FR FR-2023-08-01 88 146